Page last updated: 2024-10-31

mianserin and Coagulation Disorders, Blood

mianserin has been researched along with Coagulation Disorders, Blood in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baettig, D1
Tillement, JP1
Baumann, P1

Other Studies

1 other study available for mianserin and Coagulation Disorders, Blood

ArticleYear
Interaction between mianserin and acenocoumarin: a single case study.
    International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:4

    Topics: Acenocoumarol; Amiodarone; Blood Coagulation Disorders; Depressive Disorder; Drug Interactions; Huma

1994
chemdatabank.com